Global Contract Pharmaceutical Manufacturing Market Research Report 2020

Contract Pharmaceutical Manufacturing refers to accept commissioned from pharmaceutical companies, provide the service about API production, agent production, packaging and son on which required for pharmaceutical manufacturing.
Contract Pharmaceutical Manufacturing refers to accept commissioned from pharmaceutical companies, provide the service about API production, agent production, packaging and so on, which required for pharmaceutical manufacturing. The main type of contract pharmaceutical manufacturing is API and FDF.

The contract pharmaceutical manufacturing industry is not very concentrated the revenue of top eighteenth manufacturers account about 22% of global revenue.

In the world wide, the major manufactures mainly distribute in North America and Europe. The transnational companies, like Catalent and DPx, are the leading manufactures in the World.

North America and Europe is the industry's leading region. In 2015, the revenue of contract pharmaceutical manufacturing is about 19 billion USD in North America; its proportion of total global revenue exceeds 32%. In 2015, the revenue is about 14 billion USD in Europe. Japan and India have witnessed a major chunk developing of the contract pharmaceutical manufacturing in the Asia region. Especially India, its revenue is 8 billion USD in 2015.

The global Contract Pharmaceutical Manufacturing market is valued at 77540 million US$ in 2020 is expected to reach 116340 million US$ by the end of 2026, growing at a CAGR of 5.9% during 2021-2026.
This report focuses on Contract Pharmaceutical Manufacturing volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Contract Pharmaceutical Manufacturing market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan etc.
Market Segment Analysis
The research report includes specific segments by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type, the Contract Pharmaceutical Manufacturing market is segmented into
API
FDF

Segment by Application
Specialty/Midsize
Generics
Big Pharma
Other

Global Contract Pharmaceutical Manufacturing Market: Regional Analysis
The Contract Pharmaceutical Manufacturing market is analysed and market size information is provided by regions (countries). The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type and by Application segment in terms of sales and revenue for the period 2015-2026.
The key regions covered in the Contract Pharmaceutical Manufacturing market report are:
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Global Contract Pharmaceutical Manufacturing Market: Competitive Analysis
This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.
The major players in global Contract Pharmaceutical Manufacturing market include:
Catalent
DPx
Lonza
Piramal Healthcare
Aenova
Jubilant
Famar
Boehringer Ingelheim
Fareva Holding
AbbVie
Nipro Corp
Vetter
Sopharma
DPT Laboratories
Recipharm
NextPharma
Dishman
Aesica